Regeneron Pharma (REGN) PT Lowered to $979 at Bernstein Amid 'Eylea Headwinds'
Tweet Send to a Friend
Bernstein SocGen Group analyst William Pickering lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $979.00 (from $1,010.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
